Zdrowie i gospodarka · 28/12/2007

FDA Expands Labeling Flexibility for Products in Strategic National Stockpile

The FDA is issuing new regulations allowing FDA Center Directors to grant exceptions or alternatives to certain labeling requirements for human drugs, biological products, or medical devices in the Strategic National Stockpile, aiming to ensure product safety and availability during emergency situations.